Latest News
From the Journals
Which migraine medications are most effective?
“Our findings that triptans, ergots, and antiemetics are the most effective classes of medications align with the guideline recommendations and...
Latest News
Bimekizumab shows promise for palmoplantar pustular psoriasis
Treatment was well tolerated, and also improved nail involvement and joint pain.
Latest News
Tape strips detect hidradenitis suppurativa biomarkers, novel study shows
The analysis is believed to be the first of its kind.
Latest News
New COVID variant JN.1 could disrupt holiday plans
Nearly 10,000 people were hospitalized for COVID in the U.S. for the week ending Nov. 25, the CDC said, a 10%...
News
FDA approves first 2 gene-editing therapies for sickle cell
These expensive “milestone treatments” greenlighted by the FDA are the first gene-based therapies for sickle cell disease.
News
Just gas? New study on colic suggests some longer-term implications
Colic may reflect a bit more than most of us have been taught and shouldn’t necessarily be “shrugged off.”
Conference Coverage
Link between vitamin D deficiency and obesity unclear
“It appears that obesity could predict low vitamin D levels (not necessarily a deficiency). In turn, these low levels could cause obesity,...
From the Journals
Adverse events in childhood alter brain function
“We have certainly learned so much more over the past decade about early adversity and that it does have a profound impact on the brain and...
Latest News
Some reasons to get off the fence about COVID booster
“The body of evidence from all these different studies converge on one single reality — that vaccines reduce the risk of long COVID.”
From the Journals
Elagolix curbs heavy bleeding linked to uterine leiomyomas
Oral elagolix was well tolerated and offers a nonsurgical alternative for premenopausal patients.
Latest News
Antihypertensives show similar long-term mortality rates
Mortality was not significantly different among users of three different antihypertensives over a follow-up of up to 32 years.